EverQuote (EVER)
(Delayed Data from NSDQ)
$24.83 USD
-1.06 (-4.08%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $24.76 -0.07 (-0.26%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$24.83 USD
-1.06 (-4.08%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $24.76 -0.07 (-0.26%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
Zacks News
Why EverQuote (EVER) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons Why Lemonade (LMND) Stock is an Attractive Pick Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from higher net added customers, growth in overall average policy value, expanded geographic footprint and a solid capital position.
EverQuote (EVER) Surges 89.6% YTD: Will the Rally Last?
by Zacks Equity Research
EverQuote (EVER) stock rallies on the back of higher consumer traffic, solid performance of automotive and other insurance marketplace verticals, favorable growth estimates and solid capital position.
Why Is EverQuote (EVER) Down 12% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wall Street Analysts Think EverQuote (EVER) Could Surge 34.55%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 34.6% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Beat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Here's Why You Should Add Radian Group (RDN) in Your Portfolio
by Zacks Equity Research
Radian Group (RDN) stands to gain from strong persistency rates, improved new insurance written, a strong capital position, favorable growth estimates and effective capital deployment.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Radian (RDN) Okays Buyback to Boost Shareholder Returns
by Zacks Equity Research
Radian (RDN) board approves an increase of $600 million to its existing $300 million share buyback program to distribute wealth to shareholders.
Will EverQuote (EVER) Gain on Rising Earnings Estimates?
by Zacks Equity Research
EverQuote (EVER) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Should You Retain Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Assurant (AIZ) stands to gain from a well-performing Global Lifestyle business, growth of fee-based capital-light businesses, solid capital management and effective capital deployment.
MGIC Investment (MTG) Up 38.8% in a Year: Will the Rally Last?
by Zacks Equity Research
MGIC Investment (MTG) stock rallies on the back of solid insurance in force, a decline in loss and claims payment, better housing market fundamentals and prudent capital deployment.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why You Should Retain Voya Financial (VOYA) Stock
by Zacks Equity Research
Voya Financial (VOYA) stands to gain from favorable retention, positive impacts of the Benefitfocus buyout, higher investment income and surplus income.
Reasons Why Investors Should Retain Everest Group (EG) Stock
by Zacks Equity Research
Everest Group (EG) is well-poised for growth on the back of an improved interest rate environment, strong renewal retention, continued favorable rate increases and a solid capital position.
Prudential (PRU) Rises 52.3% in a Year: Will the Rally Last?
by Zacks Equity Research
Prudential (PRU) stock rallies on the back of improved spread income, strategic acquisitions, favorable variable investment income, strong underwriting results and a solid financial position.
Wall Street Analysts Believe EverQuote (EVER) Could Rally 25.37%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 25.4% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Is EverQuote (EVER) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how EverQuote (EVER) and Goldman Sachs (GS) have performed compared to their sector so far this year.
EverQuote (EVER) Is Up 11.25% in One Week: What You Should Know
by Zacks Equity Research
Does EverQuote (EVER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Assurant (AIZ) Q1 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Assurant's (AIZ) first-quarter results reflect solid performance in the Global Housing and Global Lifestyle segments, partially offset by higher expenses and weakness in Corporate & Other.
EverQuote (EVER) Q1 Earnings Top Estimates, Revenues Fall Y/Y
by Zacks Equity Research
EverQuote (EVER) first-quarter 2024 results reflect the early stages of auto carrier recovery.
Compared to Estimates, EverQuote (EVER) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for EverQuote (EVER) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EverQuote (EVER) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 171.43% and 12.77%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Fidelis Insurance Holdings (FIHL) Q1 Earnings Expected to Decline
by Zacks Equity Research
Fidelis Insurance (FIHL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Radian (RDN) Tops Q1 Earnings Estimates
by Zacks Equity Research
Radian (RDN) delivered earnings and revenue surprises of 24.10% and 3.06%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?